SCHEMBL30377129

SCHEMBL30377129

Cn1cnc2c(-c3ccc(OC(F)(F)F)cc3)cc(N)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 1/20 0.41
▸ TEAD4 Q15561 1/20 0.41
▸ TEAD2 Q15562 1/20 0.41
▸ TEAD3 Q99594 1/20 0.41
▸ SCN5A Q14524 5/20 0.40
▸ SCN10A Q9Y5Y9 5/20 0.40
▸ KCNH2 Q12809 2/20 0.40
▸ SCN9A Q15858 2/20 0.40
▸ SCN1A P35498 1/20 0.40
▸ SCN2A Q99250 1/20 0.40
▸ SCN8A Q9UQD0 1/20 0.40
▸ KDM5A P29375 1/20 0.39
▸ KDM2B Q8NHM5 1/20 0.39
▸ KDM4C Q9H3R0 1/20 0.39
▸ KDM5B Q9UGL1 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CTSS P25774 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25289146 1.00 TEAD1 (0.41) TEAD1TEAD4TEAD2TEAD3SCN5A
SCHEMBL25749393 0.86 TEAD1 (0.41) TEAD1TEAD4TEAD2TEAD3SCN5A
SCHEMBL25293802 0.85 TEAD1 (0.43) TEAD1TEAD4TEAD2TEAD3SCN5A
SCHEMBL25245411 0.84 ALOX5AP (0.44) SCN5ASCN9ASCN2AGAACTSD
SCHEMBL31135913 0.84 ALOX5AP (0.44) SCN5ASCN9ASCN2AGAACTSD
SCHEMBL25250532 0.81 FNTB (0.47) TEAD1TEAD4TEAD2TEAD3SCN5A
SCHEMBL30377191 0.81 FNTB (0.47) TEAD1TEAD4TEAD2TEAD3SCN5A
SCHEMBL30377004 0.81 KDM5A (0.53) TEAD1TEAD4TEAD2TEAD3SCN5A
SCHEMBL25247701 0.81 KDM5A (0.53) TEAD1TEAD4TEAD2TEAD3SCN5A
SCHEMBL25251475 0.80 TEAD1 (0.48) TEAD1TEAD4TEAD2TEAD3SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436969-A2 BICYCLIC THERAPEUTIC COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER Genentech, Inc. (US) 2024-10-02 — — EP disclosed
CN-118451077-A Bicyclic therapeutic compounds and methods for treatment of cancer 基因泰克公司 2024-08-06 — — CN disclosed
WO-2023097194-A2 THERAPEUTIC COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2023-06-01 — — WO disclosed
Send feedback